These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6330605

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. II. Antinociceptive tolerance and physical dependence.
    Gwynn GJ, Domino EF.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):312-6. PubMed ID: 6092614
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

  • 47. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
    Schmauss C.
    Eur J Pharmacol; 1987 Jun 04; 137(2-3):197-205. PubMed ID: 2886350
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET.
    Alcohol Drug Res; 1987 Jun 04; 6(5):327-39. PubMed ID: 3011025
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW.
    Proc Natl Acad Sci U S A; 1980 Jun 04; 77(6):3691-4. PubMed ID: 6251477
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Effects of full and partial kappa agonists and mu agonists on urine output of normally hydrated rats.
    Leander JD.
    Neuropeptides; 1984 Dec 04; 5(1-3):283-6. PubMed ID: 6099514
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May 04; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 57. Cross-tolerance of associative and nonassociative morphine tolerance in the rat with mu- and kappa-specific opioids.
    Carter BL, Tiffany ST.
    Psychopharmacology (Berl); 1996 Feb 04; 123(3):289-96. PubMed ID: 8833422
    [Abstract] [Full Text] [Related]

  • 58. Tolerance and cross-tolerance studies with morphine and ethylketocyclazocine.
    Porreca F, Cowan A, Raffa RB, Tallarida RJ.
    J Pharm Pharmacol; 1982 Oct 04; 34(10):666-7. PubMed ID: 6128391
    [No Abstract] [Full Text] [Related]

  • 59. Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey.
    Locke KW, Brown DR, Holtzman SG.
    Pharmacol Biochem Behav; 1982 Dec 04; 17(6):1275-9. PubMed ID: 6298835
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.